Médicament : innovation, accès au marché et commercialisation

Dossier : Dossier FFE Hors SérieMagazine N°719 Novembre 2016Par : Alain J. GILBERT, Co-Chairman de Bionest Partners.

Bionest Partners is a global consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics.

Poster un commentaire